Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04449445 · ClinicalTrials.gov registry record · NA

Perioperative Nutritional Optimization in Head and Neck Cancer Patients

A NA study of Head and Neck Cancer, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT04449445: Recruiting NA study of Head and Neck Cancer, sponsored by University of Illinois at Chicago.

NCT04449445 is a NA study of Head and Neck Cancer that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 300 participants, above the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (15% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04449445, a NA study of Head and Neck Cancer, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

To determine whether nutritional optimization in head and neck cancer patients undergoing major surgery will decrease post-operative wound complications. The Investigators hypothesize that nutritional supplementation with Nestle Impact Advanced Recovery (AR) will decrease the rate of wound complications after surgery

Primary Outcome

Assess the rate of post-operative wound infection

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Isocaloric and iso-nitrogenous standard enteral tube feeds
  • DIETARY_SUPPLEMENT Nestle IMPACT AR

Study Locations (1)

Illinois

  • University of Illinois at Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2022-05-10
Est. Completion 2026-11
Phase NA
University of Illinois at Chicago

430 total trials

What NCT04449445 shows while recruiting

NCT04449445 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (15% higher).

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 2 interventions - of which Isocaloric and iso-nitrogenous standard enteral tube feeds is the first listed.

NCT04449445 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04449445 about?

NCT04449445 is a clinical study titled "Perioperative Nutritional Optimization in Head and Neck Cancer Patients". To determine whether nutritional optimization in head and neck cancer patients undergoing major surgery will decrease post-operative wound complications. The Investigators hypothesize that nutritional supplementation with Nestle Impact Advanced Recovery (AR) will decrease the rate of wound complicat...

What is the current status of trial NCT04449445?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-05-10. Estimated completion is 2026-11.

What conditions does trial NCT04449445 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT04449445?

The interventions under investigation include: Isocaloric and iso-nitrogenous standard enteral tube feeds (DIETARY_SUPPLEMENT), Nestle IMPACT AR (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04449445?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04449445 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04449445's enrollment target sits among peer trials

300 35th of 250 higher than 214 of 250 other Head and Neck Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Head and Neck Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04449445, the US trial registry maintained by the National Library of Medicine. NCT04449445 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.